+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immunochemistry Analyzers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

  • PDF Icon

    Report

  • 189 Pages
  • June 2022
  • Region: Global
  • GlobalData
  • ID: 5625065
The publisher's Medical Devices sector report, 'Immunochemistry Analyzers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update' provides comprehensive information about the Immunochemistry Analyzers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Immunochemistry analyzers are analytical laboratory equipment used to perform tests for infectious diagnostics, specific proteins and therapeutic drugs.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Immunochemistry Analyzers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Immunochemistry Analyzers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy


The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Immunochemistry Analyzers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Immunochemistry Analyzers Overview
3 Products under Development
3.1 Immunochemistry Analyzers - Pipeline Products by Stage of Development
3.2 Immunochemistry Analyzers - Pipeline Products by Segment
3.3 Immunochemistry Analyzers - Pipeline Products by Territory
3.4 Immunochemistry Analyzers - Pipeline Products by Regulatory Path
3.5 Immunochemistry Analyzers - Pipeline Products by Estimated Approval Date
4 Immunochemistry Analyzers - Pipeline Products under Development by Companies
4.1 Immunochemistry Analyzers Companies - Pipeline Products by Stage of Development
4.2 Immunochemistry Analyzers - Pipeline Products by Stage of Development
5 Immunochemistry Analyzers Companies and Product Overview6 Immunochemistry Analyzers- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Immunochemistry Analyzers - Pipeline Products by Stage of Development
  • Immunochemistry Analyzers - Pipeline Products by Segment
  • Immunochemistry Analyzers - Pipeline Products by Territory
  • Immunochemistry Analyzers - Pipeline Products by Regulatory Path
  • Immunochemistry Analyzers - Pipeline Products by Estimated Approval Date
  • Immunochemistry Analyzers Companies - Pipeline Products by Stage of Development
  • Immunochemistry Analyzers - Pipeline Products by Stage of Development
  • Glossary

List of Figures
  • Immunochemistry Analyzers - Pipeline Products by Stage of Development
  • Immunochemistry Analyzers - Pipeline Products by Segment
  • Immunochemistry Analyzers - Pipeline Products by Territory
  • Immunochemistry Analyzers - Pipeline Products by Regulatory Path
  • Immunochemistry Analyzers - Pipeline Products by Estimated Approval Date

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Astek Diagnostics
  • Atonomics A/S (Inactive)
  • Beckman Coulter Inc
  • Biosan Medical Ltd
  • BioSIMS
  • Boditech Med Inc
  • Boston University
  • BreviTest Technologies LLC
  • China Medical Technologies Inc (Inactive)
  • ChipCare Corp
  • Clearbridge BioLoc Pte Ltd
  • Corgenix Medical Corp
  • DiaSorin SpA
  • Drew Scientific Co Ltd
  • Dyamed Biotech Pte Ltd
  • Enigma Diagnostics Ltd (Inactive)
  • Euroimmun AG
  • Firalis SAS
  • GenapSys Inc
  • Genevo Biosystems Pte Ltd
  • Great Basin Scientific Inc.
  • HeatFlow Technologies Inc
  • Hokkaido University
  • Huakang Biomedical Holdings Co Ltd
  • Indian Institute of Technology Madras
  • Johnson & Johnson
  • LabNow Inc (Inactive)
  • Lucerna Inc
  • Magellan Diagnostics Inc
  • MedNostic Technologies, LLC
  • Merck Millipore Corp
  • Meridian Bioscience Inc
  • NanoLab Inc
  • Ortho Clinical Diagnostics Holdings Plc
  • PerkinElmer Inc
  • Protomex Life Sciences
  • Randox Laboratories Ltd
  • Rapid Diagnostek, Inc.
  • Siloam Biosciences, Inc.
  • Spectradyne LLC
  • Tecan Group Ltd
  • The Palo Alto Research Center
  • Tyncbest Biotechnology
  • University of Illinois at Urbana-Champaign
  • University of Michigan Pediatric Device Consortium
  • University of South Florida
  • University of Southern California
  • Virogenomics BioDevelopment Inc
  • Xanthostat Diagnostics Inc
  • Yunnan Energy International Co Ltd